Targeting PNPLA3 I148M variant in MASLD: Cell-type specific mechanisms and precision therapy opportunities
{{output}}
The PNPLA3 I148M variant is the primary genetic risk factor for metabolic dysfunction-associated steatotic liver disease, representing the most promising target for interventions in this increasingly prevalent disease. In this review, we describe the lipotoxic... ...
